LA JOLLA, Calif.--(BUSINESS WIRE)--CHI-California Healthcare Institute announced today that Paul Hastings, president and chief executive officer of OncoMed Pharmaceuticals, and Ken Berger, president of the Specialty Diagnostics business for Thermo Fisher Scientific, have been elected to its board of directors. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.
